We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Methylation Enzyme Modifies Gene Behavior

By Biotechdaily staff writers
Posted on 24 May 2002
An enzyme has been found that attaches methyl groups to histone proteins and represses the activity of certain genes. More...
The research was reported in the April 15, 2002, issue of Genes and Development.

Histone proteins are packaged together with DNA in the chromosomes. If methylation of these proteins is blocked, genes that normally are repressed may become activated. Such activated genes may transform normal cells into cancerous ones.

"In this study we showed that when this enzyme is active at a particular gene, it places a molecular marker on the gene, says Dr. Frank J. Rauscher III, a professor at The Wistar Institute (Philadelphia, PA, USA). "This molecular marker is crucial in silencing sets of genes.” Loss of this molecular marker from a particular set of genes in a normally nonaggressive breast cancer can cause it to become very aggressive and metastatic.

"Now that we have found a new enzyme that is required for the silencing of certain genes,” states Dr. Rauscher, "we believe it will be possible to create specific drugs that can either repress or activate gene expression through the targeting of this enzyme. This could lead to therapies for cancer and, specifically, for controlling the metastatic spread of cancer.”




Related Links:
The Wistar Institute

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.